42 U.S.C. 1395w-104: Beneficiary protections for qualified prescription drug coverage

2022

• Pub. L. 117–169, §11201(e)(2), substituted "for a year preceding 2025, the initial" for "the initial". Law text · (a)
• Pub. L. 117–169, §11001(b)(1)(E), added subpar. (I). Law text · (b)

2020

• Pub. L. 116–136 added par. (4). (Coronavirus Aid, Relief, and Economic Security Act" or the "CARES Act) Law text · (b)
• Pub. L. 116–260, §119(a)(1), redesignated subsec. (m), relating to program integrity transparency measures, as (n). (Consolidated Appropriations Act, 2021) Law text · (m), (n)
• Pub. L. 116–260, §119(a)(2), added subsec. (o). (Consolidated Appropriations Act, 2021) Law text · (o)

2018

• Pub. L. 115–271, §6102(1), inserted ", subject to subparagraph (C)," before "including". (Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment for Patients and Communities Act" or the "SUPPORT for Patients and Communities Act) Law text · (a)
• Pub. L. 115–271, §6102(2), added cl. (vi). (Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment for Patients and Communities Act" or the "SUPPORT for Patients and Communities Act) Law text · (a)
• Pub. L. 115–271, §6102(3), added subpar. (C). (Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment for Patients and Communities Act" or the "SUPPORT for Patients and Communities Act) Law text · (a)
• Pub. L. 115–271, §2004(1), added subpar. (F). (Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment for Patients and Communities Act" or the "SUPPORT for Patients and Communities Act) Law text · (c)
• Pub. L. 115–271, §6064, substituted "are the following:" for "are part D eligible individuals who—" in introductory provisions, added subcls. (I) and (II), redesignated former subcls. (I) to (III) as items (aa) to (cc), respectively, of subcl. (I), and realigned margins. (Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment for Patients and Communities Act" or the "SUPPORT for Patients and Communities Act) Law text · (c)
• Pub. L. 115–271, §6103(b), struck out "may include elements that promote" after "program" in introductory provisions, added cls. (i) and (ii), redesignated former cls. (i) to (iii) as subcls. (I) to (III), respectively, of cl. (i), and realigned margins. (Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment for Patients and Communities Act" or the "SUPPORT for Patients and Communities Act) Law text · (c)
• Pub. L. 115–271, §6065, added subpar. (D). (Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment for Patients and Communities Act" or the "SUPPORT for Patients and Communities Act) Law text · (c)
• Pub. L. 115–271, §2004(2), inserted "(and for plan years beginning on or after January 1, 2022, a PDP sponsor shall)" after "A PDP sponsor may". (Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment for Patients and Communities Act" or the "SUPPORT for Patients and Communities Act) Law text · (c)
• Pub. L. 115–271, §2007(a)(1), substituted ", including notice that if on reconsideration a PDP sponsor affirms its denial, in whole or in part, the case shall be automatically forwarded to the independent, outside entity contracted with the Secretary for revie… (Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment for Patients and Communities Act" or the "SUPPORT for Patients and Communities Act) Law text · (c), (iii)
• Pub. L. 115–271, §2006(1), substituted "Except as provided in clause (v), for purposes" for "For purposes". (Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment for Patients and Communities Act" or the "SUPPORT for Patients and Communities Act) Law text · (c)
• Pub. L. 115–271, §2006(2), added cl. (v). (Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment for Patients and Communities Act" or the "SUPPORT for Patients and Communities Act) Law text · (c)
• Pub. L. 115–271, §2007(a)(2), substituted "and if on reconsideration a PDP sponsor affirms its denial, in whole or in part, the case shall be automatically forwarded to the independent, outside entity contracted with the Secretary for review and resolution." for "and the option o… (Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment for Patients and Communities Act" or the "SUPPORT for Patients and Communities Act) Law text · (c)
• Pub. L. 115–123 added par. (6) relating to providing prescription drug plans with parts A and B claims data to promote the appropriate use of medications and improve health outcomes. (Bipartisan Budget Act of 2018) Law text · (c)
• Pub. L. 115–271, §6062, added subpar. (E). (Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment for Patients and Communities Act" or the "SUPPORT for Patients and Communities Act) Law text · (e)
• Pub. L. 115–271, §2003(a), added par. (7). (Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment for Patients and Communities Act" or the "SUPPORT for Patients and Communities Act) Law text · (e)
• Pub. L. 115–271, §6063(c), added subsec. (m) relating to program integrity transparency measures. (Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment for Patients and Communities Act" or the "SUPPORT for Patients and Communities Act) Law text · (m)
• Pub. L. 115–262 added subsec. (m) relating to prohibition on limiting certain information on drug prices. (Know the Lowest Price Act of 2018) Law text · (m)

2016

• Pub. L. 114–198, §704(a)(2), added cl. (v). (Comprehensive Addiction and Recovery Act of 2016) Law text · (a)
• Pub. L. 114–198, §704(b)(1), added subpar. (E). (Comprehensive Addiction and Recovery Act of 2016) Law text · (c)
• Pub. L. 114–198, §704(a)(1), added par. (5). (Comprehensive Addiction and Recovery Act of 2016) Law text · (c)
• Pub. L. 114–198, §704(b)(2), added par. (6). (Comprehensive Addiction and Recovery Act of 2016) Law text · (c)

2015

• Pub. L. 114–10 added par. (4). (Medicare Access and CHIP Reauthorization Act of 2015) Law text · (c)

2010

• Pub. L. 111–148, §3307(a), amended subpar. (G) generally. Prior to amendment, subpar. (G) related to required inclusion of drugs in certain categories and classes. (Patient Protection and Affordable Care Act) Law text · (b)
• Pub. L. 111–148, §3312(a), added subpar. (H). (Patient Protection and Affordable Care Act) Law text · (b)
• Pub. L. 111–148, §10328(a), added subpars. (C) to (E) and redesignated former subpars. (C) to(E) as (E) to (G), respectively. (Patient Protection and Affordable Care Act) Law text · (c)
• Pub. L. 111–148, §3310(a), added par. (3). (Patient Protection and Affordable Care Act) Law text · (c)

2008

• Pub. L. 110–275, §176(1), substituted "Subject to subparagraph (G), the formulary" for "The formulary". (Medicare Improvements for Patients and Providers Act of 2008) Law text · (b)
• Pub. L. 110–275, §176(2), added subpar. (G). (Medicare Improvements for Patients and Providers Act of 2008) Law text · (b)
• Pub. L. 110–275, §103(a)(2), added subsec. (l). (Medicare Improvements for Patients and Providers Act of 2008) Law text · (l)
• Pub. L. 110–275, §103(b)(2), added par. (2). (Medicare Improvements for Patients and Providers Act of 2008) Law text · (l)
• Pub. L. 110–275, §103(c)(2), added par. (3). (Medicare Improvements for Patients and Providers Act of 2008) Law text · (l)
• Pub. L. 110–275, §103(d)(2), added par. (4). (Medicare Improvements for Patients and Providers Act of 2008) Law text · (l)